The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Significance of the estrogen signaling pathway in EGFR wild-type lung adenocarcinoma.
Kazumi Tanaka
No relevant relationships to disclose
Kimihiro Shimizu
No relevant relationships to disclose
Toshiteru Nagashima
No relevant relationships to disclose
Yoichi Ohtaki
No relevant relationships to disclose
Kyoichi Kaira
No relevant relationships to disclose
Jun Horiguchi
No relevant relationships to disclose
Tetsunari Oyama
No relevant relationships to disclose
Izumi Takeyoshi
No relevant relationships to disclose